Part 4/10:
Loyal has taken significant steps to validate the efficacy of LY002 through extensive studies involving more than 1,000 dogs across various veterinary clinics. The broader implications of this research could extend to human life—gaining insights about aging through canine studies could yield ground-breaking treatments for humans. While the primary focus is on improving the lives of dogs, the potential learning that arises might create pathways to human health advancements.